Skip to main content
. 2021 Jul 18;11(5):1851–1860. doi: 10.1007/s13555-021-00573-1

Fig. 1.

Fig. 1

Misalignment of a first-line and b second-line selection by class based on formulary. IL interleukin, TNF tumor necrosis factor